# Alacrita Consulting Limited

Alacrita is a London-based life science consulting firm specialising in guiding biotech and pharmaceutical companies through complex product development, commercialisation and business challenges. The firm brings together a core team of seasoned consultants with deep expertise across drug development, regulatory affairs, and commercial strategy.

The company serves a diverse clientele including early-stage biotech ventures, established pharmaceutical companies, investors evaluating life science opportunities, and academic institutions seeking to commercialise research. Their approach is particularly valuable for virtual and semi-virtual biotechs that lack in-house expertise across multiple disciplines.

What distinguishes Alacrita is their comprehensive service portfolio spanning the entire lifecycle of pharmaceutical development and commercialisation. Rather than offering narrow expertise, they provide integrated support—from initial opportunity mapping and preclinical strategy through to clinical development, regulatory navigation, and market launch planning. Their business development team excels at structuring deals, conducting due diligence, and facilitating licensing partnerships, whilst their investor services support fundraising and valuation assessments.

The firm's strength lies in combining technical scientific rigour with commercial acumen. They deploy interim chief medical officers and virtual biotech support models, enabling companies to access senior-level strategic guidance without permanent overhead costs. Their consulting network extends their capabilities beyond the core team, whilst expert witness services demonstrate their credibility within the industry. For academic and research institutions, they bridge the gap between innovation and commercialisation, translating scientific breakthroughs into viable commercial ventures.